Figure 5
Figure 5. CD8+ T-cell populations from prf−/− mice display cell-signaling patterns indicating heightened antigenic stimulation after LCMV infection. (A) Phospho-c-Jun and IFN-γ staining of CD8+ T cells from prf−/− mice 8 days after LCMV infection. (B) Spleen cells from uninfected or LCMV-infected mice were fixed immediately ex vivo and analyzed for intracellular NFAT localization. CD8+/MHC II− cells are displayed, plotting CD8 area (a measure of cell size) against an index of nuclear localization (NLI) of NFATc1. Examples of cells with an NLI of 1 or 3 are shown. (C) NLI of CD8+/MHC II− cells from the indicated animals is plotted. (D) Percentage of CD8+ cells with nuclear-localized NFATc1 (NLI > 2) from uninfected and infected mice are displayed. P < .001 when comparing the NLI of CD8+ cells from LCMV-infected WT and prf−/− mice. Data are representative of 3 experiments.

CD8+ T-cell populations from prf−/− mice display cell-signaling patterns indicating heightened antigenic stimulation after LCMV infection. (A) Phospho-c-Jun and IFN-γ staining of CD8+ T cells from prf−/− mice 8 days after LCMV infection. (B) Spleen cells from uninfected or LCMV-infected mice were fixed immediately ex vivo and analyzed for intracellular NFAT localization. CD8+/MHC II cells are displayed, plotting CD8 area (a measure of cell size) against an index of nuclear localization (NLI) of NFATc1. Examples of cells with an NLI of 1 or 3 are shown. (C) NLI of CD8+/MHC II cells from the indicated animals is plotted. (D) Percentage of CD8+ cells with nuclear-localized NFATc1 (NLI > 2) from uninfected and infected mice are displayed. P < .001 when comparing the NLI of CD8+ cells from LCMV-infected WT and prf−/− mice. Data are representative of 3 experiments.

Close Modal

or Create an Account

Close Modal
Close Modal